We are live on ! Find out more
VKTXW

Viking Therapeutics, Inc.
VKTXW

Delisted

VKTXW was delisted on the 8th of April, 2021.

Back to rankings

2 hedge funds and large institutions have $175K invested in Viking Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

230% more capital invested

Capital invested by funds: $53K → $175K (+$122K)

100% more funds holding

Funds holding: 1 → 2 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
$83K
Puts
–
Net Calls
+$83K
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$129K

Top Sellers

1
SM
Sabby Management
Florida
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$136K +$129K +302,700 New
SM
2
Sabby Management
Florida
$39K -$13K -30,659 -26%

VKTXW Hedge Fund Activity: Q4 2016 in Review

2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q4 2016, worth a combined $175K — up 230% from $53K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new VKTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $129K. The largest seller was Sabby Management, cutting an estimated $13K.

  • 2 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q4 2016, up from 1 in Q3 2016.
  • Funds reported $175K of Viking Therapeutics, Inc. stock for Q4 2016, up 230% quarter-over-quarter.
  • 1 fund opened new Viking Therapeutics, Inc. positions in Q4 2016 and 0 closed out, a net change of +1 holder.
  • The largest Viking Therapeutics, Inc. buyer in Q4 2016 was Susquehanna International Group, an estimated $129K added.
  • The largest Viking Therapeutics, Inc. seller in Q4 2016 was Sabby Management, an estimated $13K sold.

Based on aggregated 13F filings for Q4 2016.